Followers | 197 |
Posts | 24331 |
Boards Moderated | 0 |
Alias Born | 04/03/2010 |
Wednesday, December 08, 2021 8:23:39 PM
Drugs taking decades to be approved is not unique to NWBO or DCVax. That's why big drug companies let you and I fund it quite often, it's like wildcatting, but it's not unregulated like wildcatting, it is incredibly regulated. And if you want to get into new areas like biotech and not just pharmaceutical / chemical drugs, and if you want to be on the cutting edge of modern technologies to, for instance, create a custom made vaccine for a patient's specific cancer tumor, you can bet it will take a long time.
Unfortunately, we are all are so excited but can often come to think this is like every other drug or complex process, some of which have been run in huge, almost inexhaustible budgets. This is being done at this point on a shoe string budget also because of the short attacks.
Could they have sold out to someone for cheap? I bet they could have. When it was at $150 million, they could have sold off 3/4ths of it or the whole thing to a big drug company for $300 million, maybe with 30 million shares, $10, very little dilution. The investors don't feel bad, but they get bought out early, and then maybe the big Pharma company just tucks this baby in a basement somewhere or smothers it.
There are different ways they could have made shareholder's happy sooner. That is not always entirely the aim.
Recent NWBO News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
FEATURED Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • Apr 17, 2024 8:00 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM
Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM
Branded Legacy, Inc. Reports Significant Net Income of Over $3.8 Million • BLEG • Apr 16, 2024 8:30 AM